Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?
Author:
Open Access
- 28 August 2021
- journal article
- editorial
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (12) , 3823-3824
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutationsAmerican Journal of Transplantation, 2021
- Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL)Frontiers in Immunology, 2020
- Immunopathology and biology-based treatment of steroid-refractory graft-versus-host diseaseBlood, 2020
- Post‐haematopoietic cell transplantation outcomes: why ST2 became a ‘golden nugget’ biomarkerBritish Journal of Haematology, 2020
- Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trialThe Lancet Haematology, 2019
- Clinical consequences of clonal hematopoiesis of indeterminate potentialBlood Advances, 2018
- ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical ImplicationsPathobiology, 2018
- Graft Versus Host Disease After Liver Transplantation in AdultsTransplantation, 2016